Sarepta Therapeutics: 2Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Sarepta Therapeutics Inc. (SRPT) on Wednesday reported a loss of $276.4 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of $3.74 per share.
The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.08 per share.
The biopharmaceutical company posted revenue of $94.7 million in the period, which beat Street forecasts. Eight analysts surveyed by Zacks expected $91.3 million.
Sarepta Therapeutics shares have climbed 30% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $142.26, an increase of 17% in the last 12 months.